THTae Hyun Hwang

Tae Hyun Hwang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tae Hyun Hwang has a total of 339 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Geometry-First Generative Spatial Single-Cell Reconstruction

    by Ehtesamul Azim, Muhtasim Noor Alif, Tae Hyun Hwang, Yanjie Fu, Wei Zhang


  • Open Access

    SIRT2-mediated deacetylation of LCK governs the magnitude of T cell receptor signaling

    by Imene Hamaidi, Pingyan Cheng, Soo Young Jun, Alak Manna, Min-Hsuan Wang, Anh Nguyen, Ismail Can, Min G. Zhang, Odesha O. Taylor, Luis Uriel Lopez Bailon, et al.

    T cell receptor (TCR) signaling is precisely tuned to prevent self-reactivity while allowing protective immunity. Here we found that acetylation modulated TCR signaling. The loss of SIRT2 deacetylase activity in T cells led to amplified calcium mobilization and phosphorylation of key proximal TCR molecules in naive T cells and reversed dampened TCR signaling in anergic T cells. During thymic selection, SIRT2 deficiency lowered the TCR signaling threshold and resulted in a broader TCR repertoire diversity. Mechanistically, we identified acetyl-lysine K228 on the linker region of LCK as a substrate specific for SIRT2 that governed LCK conformation and activity. SIRT2 inhibition in exhausted mouse and human tumor-infiltrating T cells restored TCR responsiveness and antitumor immunity. These findings highlighted SIRT2-modulated protein acetylation as a regulatory mechanism that set the TCR threshold in T cells.


  • Open Access

    Supplementary Figures S1-S4 from ACTA2 Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer

    by Sunho Park, John D. Karalis, Changjin Hong, Jean R. Clemenceau, Matthew R. Porembka, In-Ho Kim, Sung Hak Lee, Sam C. Wang, Jae-Ho Cheong, Tae Hyun Hwang

    Supplementary Figure 1. ACTA2 expression was elevated in the molecular subtype with the worst prognosis (Group 4). Supplementary Figure 2. ACTA2 expression stratified by microsatellite stability status in the pooled cohort. Supplementary Figure 3. Alternatively tested thresholds to stratify patients into ACTA2-High and ACTA2-Low groups.Supplementary Figure 4. ACTA2 expression stratified by microsatellite stability status in the immune checkpoint inhibitor cohort.

  • Open Access

    Supplementary Tables S1-S10 from ACTA2 Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer

    by Sunho Park, John D. Karalis, Changjin Hong, Jean R. Clemenceau, Matthew R. Porembka, In-Ho Kim, Sung Hak Lee, Sam C. Wang, Jae-Ho Cheong, Tae Hyun Hwang

    Supplementary Table 1. Univariable associations of the multivariable Cox proportional hazards model in the Yonsei cohort.Supplementary Table 2. Clinical characteristics of patients in the pooled validation cohort.Supplementary Table 3. Univariable associations of the multivariable Cox proportional hazards model of the pooled validation cohort.Supplementary Table 4. Univariable Cox proportional hazards regression of the association of individual genes of the 32-gene signature and their association with overall survival in the Yonsei cohort.Supplementary Table 5. Univariable Cox proportional hazards regression of the association of individual genes of the 32-gene signature and their association with overall survival in the pooled cohort.Supplementary Table 6. Multivariable analysis of the pooled cohort including microsatellite stability status.Supplementary Table 7. Multivariable analysis of the association of ACTA2 expression with recurrence-free survival in the pooled cohort.Supplementary Table 8. Clinical characteristics of patients treated with immune checkpoint inhibitors.Supplementary Table 9. ACTA2 expression in cells analyzed by single nuclear RNA sequencing cohort.Supplementary Table 10. Characteristics of patients analzyed by digital spatial transcriptomics.

  • Open Access

    Data from ACTA2 Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer

    by Sunho Park, John D. Karalis, Changjin Hong, Jean R. Clemenceau, Matthew R. Porembka, In-Ho Kim, Sung Hak Lee, Sam C. Wang, Jae-Ho Cheong, Tae Hyun Hwang

    Purpose:We sought to identify biomarkers that predict overall survival (OS) and response to immune checkpoint inhibitors (ICI) for patients with gastric cancer.Experimental Design:This was a retrospective study of multiple independent cohorts of patients with gastric cancer. The association between tumor ACTA2 expression and OS and ICI response were determined in patients whose tumors were analyzed with bulk mRNA sequencing. Single-cell RNA sequencing (scRNA-seq) and digital spatial profiling data were used to compare tumors from patients with gastric cancer who did and did not respond to ICI.Results:Increasing tumor ACTA2 expression was independently associated with worse OS in a 567-patient discovery cohort [HR, 1.28 per unit increase; 95% confidence interval (CI), 1.02–1.62]. This finding was validated in three independent cohorts (n = 974; HR, 1.52 per unit increase; 95% CI, 1.34–1.73). Of the 108 patients treated with ICI, 56% of patients with low ACTA2 expression responded to ICI versus 25% of patients with high ACTA2 expression (P = 0.004). In an analysis of a publicly available scRNA-seq dataset of 5 microsatellite instability-high patients treated with ICI, the patient who responded to ICI had lower tumor stromal ACTA2 expression than the 4 nonresponders. Digital spatial profiling of tumor samples from 4 ICI responders and 5 ICI nonresponders revealed that responders may have lower ACTA2 expression in α-SMA–positive cancer-associated fibroblasts (CAF) than nonresponders (median: 5.00 vs. 5.50).Conclusions:ACTA2 expression is associated with survival and ICI response in patients with gastric cancer. ACTA2 expression in CAFs, but not in other cellular compartments, appears to be associated with ICI response.

  • Open Access

    TMPRSS11B promotes an acidified microenvironment and immune suppression in squamous lung cancer

    by Hari Shankar Sunil, Jean R Clemenceau, Anthony Grichuk, Isabel Barnfather, Sumanth R Nakkireddy, Luke Izzo, Qiang Feng, William Hartnett, Bret M Evers, Lisa Thomas, et al.

    Lung cancer is the leading cause of cancer-related deaths worldwide. Existing therapeutic options have limited efficacy, particularly for lung squamous cell carcinoma (LUSC), underscoring the critical need for the identification of new therapeutic targets. We previously demonstrated that the Transmembrane Serine Protease TMPRSS11B promotes the transformation of human bronchial epithelial cells and enhances lactate export from LUSC cells. Here, we evaluate the impact of TMPRSS11B activity on the host immune system and the tumor microenvironment (TME). Tmprss11b depletion significantly reduces tumor burden in immunocompetent mice and triggers an infiltration of immune cells. RNA FISH analysis and spatial transcriptomics in the autochthonous Rosa26-Sox2-Ires-Gfp LSL/LSL ; Nkx2-1 fl/fl ; Lkb 1 fl/fl (SNL) model reveal an enrichment of Tmprss11b expression in LUSC tumors, specifically in Krt13 + hillock-like cells. Furthermore, utilizing ultra-pH-sensitive nanoparticle imaging and metabolite analysis, we identify regions of acidification, elevated lactate, and enrichment of immunosuppressive (M2-like) macrophages in LUSC tumors. These results demonstrate that TMPRSS11B promotes an acidified and immunosuppressive TME and nominate this enzyme as a therapeutic target in LUSC.


  • Open Access

    Scaling up spatial transcriptomics for large-sized tissues: uncovering cellular-level tissue architecture beyond conventional platforms with iSCALE

    by Amelia Schroeder, Melanie L. Loth, Chunyu Luo, Sicong Yao, Hanying Yan, Daiwei Zhang, Sarbottam Piya, Edward Plowey, Wenxing Hu, Jean R. Clemenceau, et al.

    Recent advances in spatial transcriptomics (ST) technologies have transformed our ability to profile gene expression while preserving crucial spatial context within tissues. However, existing ST platforms are constrained by high costs, long turnaround times, low resolution, limited gene coverage and inherently small tissue capture areas, which hinder their broad applications. Here we present iSCALE, a method that reconstructs large-scale, super-resolution gene expression landscapes and automatically annotates cellular-level tissue architecture in samples exceeding capture areas of current ST platforms. The performance of iSCALE was assessed by comprehensive evaluations involving benchmarking experiments, immunohistochemistry staining and manual annotations by pathologists. When applied to multiple sclerosis human brain samples, iSCALE uncovered lesion-associated cellular characteristics undetectable by conventional ST experiments. Our results demonstrate the utility of iSCALE in analyzing large tissues by enabling unbiased annotation, resolving cell type composition, mapping cellular microenvironments and revealing spatial features beyond the reach of standard ST analysis or routine histopathological assessment.


  • Open Access

    Biological Pathway Guided Gene Selection Through Collaborative Reinforcement Learning

    by Ehtesamul Azim, Dongjie Wang, Tae Hyun Hwang, Yanjie Fu, Wei Zhang


  • Top Cited Papers
    Open Access

    Revealing 3D microanatomical structures of unlabeled thick cancer tissues using holotomography and virtual H&E staining

    by Juyeon Park, Su-Jin Shin, Geon Kim, Hyungjoo Cho, Dongmin Ryu, Daewoong Ahn, Ji Eun Heo, Jean R. Clemenceau, Isabel Barnfather, Minji Kim, et al.

    In histopathology, acquiring subcellular-level three-dimensional (3D) tissue structures efficiently and without damaging the tissues during serial sectioning and staining remains a formidable challenge. We address this by integrating holotomography with deep learning and creating 3D virtual hematoxylin and eosin (H&E) images from label-free thick cancer tissues. This method involves measuring the tissues’ 3D refractive index (RI) distribution using holotomography, followed by processing with a deep learning-based image translation framework to produce virtual H&E staining in 3D. Applied to colon cancer tissues up to 50 µm thick—far surpassing conventional slide thickness—this technique provides direct methodological validation through chemical H&E staining. It reveals quantitative 3D microanatomical structures of colon cancer with subcellular resolution. Further validation of our method’s repeatability and scalability is demonstrated on gastric cancer samples across different institutional settings. This innovative 3D virtual H&E staining method enhances histopathological efficiency and reliability, marking a significant advancement in extending histopathology to the 3D realm and offering substantial potential for cancer research and diagnostics.


  • Open Access

    Deep Gaussian process with uncertainty estimation for microsatellite instability and immunotherapy response prediction from histology

    by Sunho Park, Morgan F. Pettigrew, Yoon Jin Cha, In-Ho Kim, Minji Kim, Imon Banerjee, Isabel Barnfather, Jean R. Clemenceau, Inyeop Jang, Hyunki Kim, et al.

    Determining tumor microsatellite status has significant clinical value because tumors that are microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) respond well to immune checkpoint inhibitors (ICIs) and oftentimes not to chemotherapeutics. We propose MSI-SEER, a deep Gaussian process-based Bayesian model that analyzes H&E whole-slide images in weakly-supervised-learning to predict microsatellite status in gastric and colorectal cancers. We performed extensive validation using multiple large datasets comprised of patients from diverse racial backgrounds. MSI-SEER achieved state-of-the-art performance with MSI prediction by integrating uncertainty prediction. We achieved high accuracy for predicting ICI responsiveness by combining tumor MSI status with stroma-to-tumor ratio. Finally, MSI-SEER’s tile-level predictions revealed novel insights into the role of spatial distribution of MSI-H regions in the tumor microenvironment and ICI response.